Harrow Health Inc
Drug Manufacturers - Specialty & Generic
Healthcare
HROW
35.83 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
47.33
52 week high
57.48
high
50.19
52 week low
0.00
low
47.32
growth
8.51 %
previous Close
46.09
P/E ratio
market cap
1.26 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
-100.00 %
net profit margin
0.00 %
37.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top